Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6025799 | 0.87 | PTGS2 (0.68) | PTGS2PTGS1 | |
| SCHEMBL7500353 | 0.86 | PTGS2 (0.67) | PTGS2PTGS1 | |
| SCHEMBL7502336 | 0.85 | PTGS2 (0.65) | PTGS2PTGS1 | |
| SCHEMBL7511025 | 0.85 | PTGS2 (0.65) | PTGS2PTGS1 | |
| SCHEMBL6022651 | 0.84 | PTGS2 (0.64) | PTGS2PTGS1 | |
| SCHEMBL215744 | 0.84 | PTGS2 (0.64) | PTGS2PTGS1 | |
| SCHEMBL7505741 | 0.83 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL8552548 | 0.83 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL7506460 | 0.83 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL7497732 | 0.82 | PTGS2 (0.61) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050085477-A1 | Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of neoplasia | PHARMACIA CORPORATION | 2005-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085477-A1 | Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of neoplasia | TPH2, TPH1, HTR2A | PTGS2 15/4885PTGS1 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.